CTRI/2017/05/008662招募中不适用
Clinical evaluation of Laksha Guggulu, Muktasukti Bhasma in the management of Osteopeniea/ Osteoporosis
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 60
- 试验地点
- 2
- 主要终点
- Improvement in BMDT
研究概览
简要总结
For the scientific validation of classical Ayurvedicformulations a multi centric clinical trial has been initiated for themanagement of Asthisaushirya (Ostoporosis/Osteopenia) as an activity underIntra Mural Clinical Research Programme. Ayurvedic medicines Laksha guggulu,Muktasukthi Bhasma selected for the study. Treatment will be given for 12weeks, Sample size is 60. Duration of the treatment is 12 weeks. Total studyperiod is 2 years.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 45.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Patients of either sex with age above 45years and upto 70 years.
- •2.B.M.D.T. Score ( -1 to -3) on DEXA Scan 3.Patient willing to participate in the clinical trial.
排除标准
- •1.Patients who are consuming corticosteroids (more than 5mg/day of prednisolone or equivalent) for more than 3 months 2.Patients with history of Fragility Fracture.
- •3.Patients suffering from congenital disorders related to bone (Dysosteogenesis, Marfan’s Syndrome, etc.) 4.Patients with (Hypothyroidism and Hyperthyroidism, Hypoparathyroidism and Hyperparathyroidism, Cushing‘s syndrome) 5.Patients suffering from Osteomalacia.
- •6.Patients suffering from Malabsorption syndrome
- •Patients who have undergone Organ transplantation 8.Patients who are immobilized since > 6 weeks 9.Patients with history of bone fracture in last 6 months.
- •10.Patients with evidence of malignancy 11.Pregnancy and lactation 12.Patients who cannot report in person once in 2 weeks in the OPD 13.Patients with poorly controlled Hypertension ( >160/100 mmHg) 14.Patients with poorly controlled Diabetes Mellitus having Hb A1C of >8 15.Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
- •16.Patients with history of Urolithiasis.
- •17.Patients with concurrent serious hepatic disorder (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin, Alkaline Phosphatase (ALP) > 2 times upper normal limit) or Renal Disorders (defined as S.
- •Creatinine >1.2mg/dl), Severe Pulmonary Dysfunction (uncontrolled Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease [COPD]), or any other condition that may jeopardize the study.
- •18.Alcoholics, smokers, and/or drug abusers 19.H/o hypersensitivity to any of the trial drugs or their ingredients 20.Patients who have completed participation in any other clinical trial during the past six months.
- •21.Patients on calcium and Vitamin D supplementation 22.Known cases of Paget’s disease of bone.
- •23.Any other condition which the Investigator thinks may jeopardize the study.
结局指标
主要结局
Improvement in BMDT
时间窗: 84th day
次要结局
- Improvement in clinical parameters(84 days)
研究者
研究点 (2)
Loading locations...
相似试验
招募中
2 期
A clinical study to see the effect of some Ayurvedic formulations in the patients of Bone loss.Osteopenia/OsteoporosisCTRI/2012/07/002775Department of AYUSH Ministry of Health Family Welfare Government of India150
已完成
2 期
A clinical study to see the effect of some Ayurvedic formulations in the management of Arthritis knee.osteoarthritis kneeCTRI/2014/02/004388Central Council for Research in Ayurvedic Sciences180
招募中
2 期
A clinical study to see the effect of some Ayurvedic formulations in the management of ObesityObesity (Sthaulya)CTRI/2012/01/002377Department of AYUSH Ministry of Health Family Welfare Government of India150
招募中
2 期
A clinical study to see the effect of some Ayurvedic formulations in the patients of Prostate enlargement.Benign Prostate Hypertrophy (BPH)CTRI/2012/04/002586Department of AYUSH Ministry of Health Family Welfare Government of India150
招募中
2 期
A clinical study to see the effect of some Ayurvedic formulations in the management of High Blood Sugar.Type II Diabetes MellitusCTRI/2012/05/002646Department of AYUSH Ministry of Health Family Welfare Government of India150